Industry Outlook for Breath Biopsy Testing Market Improves as Global Demand Increases

The Business Research Company’s Breath Biopsy Testing Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035

LONDON, GREATER LONDON, UNITED KINGDOM, November 6, 2026 /EINPresswire.com/ — “The breath biopsy testing market has been gaining considerable traction recently, driven by advancements in technology and growing demand for non-invasive diagnostic methods. This sector is set to experience substantial growth as healthcare providers increasingly adopt innovative approaches for early disease detection and management. Let’s explore the market size, key growth drivers, regional dynamics, and future trends shaping this promising field.

Anticipated Growth and Market Value of the Breath Biopsy Testing Market
The breath biopsy testing market has demonstrated strong expansion in recent years. It is projected to increase from $3.43 billion in 2025 to $3.69 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.7%. This growth during the historical period is largely due to rising demand for non-invasive diagnostic tools, increased clinical research focused on breath biomarkers, technological advancements in sensors and spectroscopy, the expansion of diagnostic laboratory services, and a growing preference among patients for painless testing options.

Download a free sample of the breath biopsy testing market report:
https://thebusinessresearchcompany.com/sample_request?id=22821103&type=smp&name=Breath%20Biopsy%20Testing%20Market%20Report%202026&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Nov_PR

Looking ahead, the market is expected to continue its upward trajectory, reaching $4.9 billion by 2030 with a CAGR of 7.3%. Factors contributing to this forecast include wider adoption of breath-based diagnostics in routine health screenings, increased investments in AI-powered diagnostic platforms, growth in personalized medicine applications, greater use of portable diagnostic devices, and stronger regulatory support for non-invasive testing methods. Emerging trends during this period will include broader utilization of non-invasive techniques, development of VOC-based disease detection, AI-driven breath analysis integration, portable breath sampling innovation, and an intensified focus on early disease detection.

Understanding Breath Biopsy Testing and Its Diagnostic Role
Breath biopsy testing offers a non-invasive diagnostic approach that examines the chemical compounds present in an individual’s exhaled breath to detect and diagnose various diseases. This method operates on the principle that certain illnesses, metabolic disorders, and physiological conditions emit unique chemical markers or volatile organic compounds (VOCs) identifiable in the breath. By analyzing these markers, clinicians can gain valuable insights into a patient’s health status without the need for invasive procedures.

View the full breath biopsy testing market report:
https://thebusinessresearchcompany.com/report/breath-biopsy-testing-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Nov_PR

Key Factors Fueling Growth in the Breath Biopsy Testing Market
One of the primary factors driving the breath biopsy testing market is the rising incidence of respiratory diseases worldwide. Respiratory conditions affect the lungs and airways, impairing breathing efficiency and overall lung function. The increasing prevalence of these diseases is linked to factors such as worsening environmental pollution, higher smoking rates, and a growing number of chronic illnesses including asthma and chronic obstructive pulmonary disease (COPD).

Breath biopsy testing offers a promising solution for respiratory disease diagnosis by providing a non-invasive, rapid, and potentially more accurate method of detecting biomarkers associated with such conditions. This capability enhances early diagnosis and improves disease management. For example, in May 2025, data from the Centers for Disease Control and Prevention (CDC) revealed that COPD was the fifth leading cause of death in the United States in 2023, resulting in 141,733 fatalities. Additionally, the age-adjusted prevalence of diagnosed COPD among adults was 3.8% during the same year. These statistics highlight the urgent need for effective diagnostic tools, reinforcing the demand for breath biopsy testing in managing respiratory illnesses.

Regional Market Leadership and Growth Outlook for Breath Biopsy Testing
In 2025, North America emerged as the dominant region in the global breath biopsy testing market. The region’s leadership is attributed to advanced healthcare infrastructure, widespread adoption of new technologies, and strong regulatory frameworks supporting innovative diagnostics.

However, the Asia-Pacific region is expected to experience the fastest growth over the forecast period. This rapid expansion is driven by increasing healthcare investments, rising awareness of non-invasive diagnostic options, growing clinical research activities, and expanding access to portable diagnostic devices. The breath biopsy testing market report also covers other key regions including South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa, providing a comprehensive global perspective on market trends and opportunities.

Our 2026 market reports now feature expanded strategic intelligence through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspots infographics, key technology and future trend analysis, along with updated graphics and tables.

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info

The Business Research Company – www.thebusinessresearchcompany.com

Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company“

Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X

Media gallery

About The Author

Written By: EIN Presswire